Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat and FYVE domain containing 1–Adaptor related protein complex 1 sigma 3 readthrough (WDFY1-AP1S3)
- Target
- WDFY1-AP1S3
- Molecular classification
- Other, WDFY1: WD repeat domain containing, Zinc finger protein, AP1S3: Adaptor protein complex subunit
01
Overview
The target known as "novel protein, WDFY1-AP1S3 readthrough" (ENSG00000286239) refers to a gene annotation describing a readthrough (transcriptional fusion) event between the WD repeat and FYVE domain containing 1 (WDFY1) and the adaptor-related protein complex 1 sigma 3 subunit (AP1S3). While both parent genes encode proteins with defined roles in immune regulation and vesicle trafficking, there is currently no evidence that the readthrough transcript or protein functions as a biologically relevant molecule or pharmaceutical target. It does not appear to be represented in therapeutic target databases, and no biological functions, disease roles, or drug interactions have been validated for this entity[4][5].
- Other names
- WDFY1-AP1S3 readthroughNovel protein, WDFY1-AP1S3 readthrough
02
Mechanism of action
None described
03
Biological functions
Unknown for the readthrough product
04
Disease associations
Unknown for the readthrough product
05
Safety considerations
None described for the readthrough product
06
Interacting drugs
None identified for the readthrough product
07
Biomarkers
None known
Beyond the preview
Go deeper on WD repeat and FYVE domain containing 1–Adaptor related protein complex 1 sigma 3 readthrough (WDFY1-AP1S3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WD repeat and FYVE domain containing 1–Adaptor related protein complex 1 sigma 3 readthrough (WDFY1-AP1S3).